Eli Aharoni
Chief Tech/Sci/R&D Officer at SAMSARA VISION, INC.
Profile
Eli Aharoni is currently working as Vice President-Research & Development, GM at Samsara Vision, Inc. He previously worked as Vice President-Finance at Acceleron Pharma, Inc. He completed his undergraduate degree from Technion-Israel Institute of Technology.
Eli Aharoni active positions
Companies | Position | Start |
---|---|---|
SAMSARA VISION, INC. | Chief Tech/Sci/R&D Officer | 01/01/2001 |
Former positions of Eli Aharoni
Companies | Position | End |
---|---|---|
ACCELERON PHARMA INC. | Director of Finance/CFO | - |
Training of Eli Aharoni
Technion-Israel Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Samsara Vision, Inc.
Samsara Vision, Inc. Medical SpecialtiesHealth Technology Samsara Vision, Inc. engages in the business of research, development, manufacturing, and marketing proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders. It operates under the United States and Other geographical segments. The company was founded by Isaac Lipshitz, David Lifschitz, Yossi Gross, Boaz Lifschitz, and Eyal Lifschitz in 1997 and is headquartered in Far Hills, NJ. | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Eli Aharoni